BTIG raised the firm’s price target on Praxis Precision (PRAX) to $843 from $507 and keeps a Buy rating on the shares. The firm views the ...
Piper Sandler raised the firm’s price target on Precision Drilling (PDS) to $81 from $79 and keeps an Overweight rating on the shares. The firm ...
Scientists engaged in precision medicine research focus intensely on target-based drug development. In doing so, they help improve the safety and efficacy profiles of future therapies by reducing ...